These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14052972)

  • 1. MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. II.
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Can Med Assoc J; 1963 Nov; 89(18):911-4. PubMed ID: 14052972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. III.
    VANCREVELD S; MOCHTAR IA; KOPPE JG
    Can Med Assoc J; 1964 May; 90(22):1248-9. PubMed ID: 14158954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [HEMOSTATIC TRANSFUSION PREPARATIONS PREPARED FROM DONOR BLOOD (ANTIHEMOPHILIC PLASMA, ANTIHEMOPHILIC GLOBULIN, FIBRINOGEN)].
    ROZENBERG GIa; RUDNITSKAIA MZ
    Probl Gematol Pereliv Krovi; 1963 Jun; 8():3-9. PubMed ID: 14070543
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE SUPPLY OF PERSONALLY PREPARED PLASMA FRACTIONS IN HEMOPHILIA A].
    GAERISCH F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 81():148-55. PubMed ID: 14165084
    [No Abstract]   [Full Text] [Related]  

  • 5. Modern aspects of the treatment of hemophilia.
    van CREVELD ; MOCHTAR IA
    Can Med Assoc J; 1962 Nov; 87(19):993-7. PubMed ID: 14023829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma transfusion in hemophilia. VIII. Effect of various plasma products on hemophilia A].
    van CREVELD ; MOCHTAR IA
    Ned Tijdschr Geneeskd; 1963 Jan; 107():155-9. PubMed ID: 14023830
    [No Abstract]   [Full Text] [Related]  

  • 7. [Transfusion of human plasma poor in fibrinogen in hemophilia A].
    van CREVELD ; MOCHTAR IA
    Hemostase; 1961; 1():75-7. PubMed ID: 13882172
    [No Abstract]   [Full Text] [Related]  

  • 8. [PLASMA TRANSFUSIONS IN HEMOPHILIA (X). EXPERIENCES WITH LYOPHILIZED 2-DONOR FIBRINOGEN].
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Ned Tijdschr Geneeskd; 1964 Apr; 108():843-4. PubMed ID: 14144908
    [No Abstract]   [Full Text] [Related]  

  • 9. EXPERIENCES IN THE PREPARATION OF AHG CONCENTRATES FROM HUMAN PLASMA.
    POOL JG; HINK JH
    Bibl Haematol; 1964; 19():146-50. PubMed ID: 14266987
    [No Abstract]   [Full Text] [Related]  

  • 10. [EXPERIMENTS CONCERNING FACTOR 8. LONGEVITY OF FACTOR 8 IN VIVO AND VITRO AND THE SUBFRACTIONATION OF FIBRINOGEN SAMPLES FROM 2 DONORS].
    MOCHTAR IA; KOPPE JG; STIBBE J
    Maandschr Kindergeneeskd; 1964 Jul; 32():440-5. PubMed ID: 14228685
    [No Abstract]   [Full Text] [Related]  

  • 11. [PLASMA TRANSFUSION IN HEMOPHILIA. IX. EXPERIENCE WITH 2-DONOR FIBRINOGEN].
    VAN CREVELD ; MOCHTAR IA; KOPPE JG
    Ned Tijdschr Geneeskd; 1963 Sep; 107():1736-9. PubMed ID: 14050958
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of classic hemophilia: the use of fibrinogen rich in factor VIII for hemorrhage and for surgery.
    MCMILLAN CW; DIAMOND LK; SURGENOR DM
    N Engl J Med; 1961 Aug; 265():277-83 concl. PubMed ID: 13774141
    [No Abstract]   [Full Text] [Related]  

  • 13. [Differential blood sedimentation after transfusions and phlebotomy].
    HELMER A
    Arztl Wochensch; 1960 Mar; 15():226-8. PubMed ID: 14400927
    [No Abstract]   [Full Text] [Related]  

  • 14. [TECHNIC OF TRANSFUSION THERAPY IN SURGERY ON HEMOPHILIACS].
    ABDULLAEV GM; KOZHEVNIKOV IN
    Probl Gematol Pereliv Krovi; 1964 Aug; 9():36-40. PubMed ID: 14252414
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preparation of a human plasmatic fraction rich in factor VIII (antihemophilic A) and poor in fibrinogen].
    NIEMETZ J; WEILLAND C; SOULIER JP
    Nouv Rev Fr Hematol; 1961; 1():880-6. PubMed ID: 14479667
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hemophilia with immunologic inhibitor of factor VIII by using "activated" coagulant fractions].
    Sultan Y; Brouet JC
    Nouv Presse Med; 1975 Oct; 4(36):2571-4. PubMed ID: 1081682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of uncontrollable, life-threatening hemorrhage].
    Stensballe J; Lethagen S; Johansson PI
    Ugeskr Laeger; 2005 Jun; 167(25-31):2789-90. PubMed ID: 16014269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative studies on modern quantitative determination methods of plasma fibrinogen].
    HIRSCH A; CATTANEO C
    Hoppe Seylers Z Physiol Chem; 1956 May; 304(2-4):53-64. PubMed ID: 13331490
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the fibrinogen content of the blood plasma in childhood. 1. Fibrinogen content of the blood plasma in normal children].
    AKABANE T
    Paediatr Jpn; 1963 Mar; 67():157-60. PubMed ID: 14011474
    [No Abstract]   [Full Text] [Related]  

  • 20. [Preparation of fibrinogen for intravenous use at a blood transfusion station].
    BILA K; FISER I; HOVEZAK V; PRINZ M
    Probl Gematol Pereliv Krovi; 1962 May; 7():43-6. PubMed ID: 13869156
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.